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His6, His13, and His14 residues 
in Aβ 1–40 peptide significantly 
and specifically affect oligomeric 
equilibria
Kaja Przygońska1, Magdalena Pacewicz1, Wiktoria Sadowska1,2, Jarosław Poznański1, 
Wojciech Bal1 & Michał Dadlez1,3
Oligomers of Aβ peptide are implicated as the most probable causative agent in Alzheimer’s disease. 
However, their structural properties remain elusive due to the dynamic and heterogeneous character 
of oligomeric species coexisting in solution. Nevertheless, new approaches, mainly based on mass 
spectrometry, provide unique access to these different structural forms. Using these methods, we 
previously showed that the N-terminal, non-amyloidogenic region of Aβ is involved in the network 
of interactions specifically stabilizing oligomers. In the present study, we identified three histidine 
residues as active participants in this network. Detailed knowledge of the structural features that are 
potentially important for oligomer-mediated neurotoxicity is a prerequisite for the rational design of 
oligomerization modifiers.
The etiology of Alzheimer’s disease (AD), a chronic, debilitating, and incurable form of dementia, has been under 
investigation for decades. Currently, the consensus points to oligomeric forms of the so-called Aβ peptide as the 
most probable main synaptotoxic and neurotoxic agent1–4. Growing evidence of the key role of small, soluble 
Aβ oligomers calls for a detailed characterization of their structure5,6. These studies, however, are hampered by 
the heterogeneity and dynamic nature of structural species arising during the transition from monomers to oli-
gomers7–9. For these reasons, classic methods of structural analysis do not readily deliver detailed information, 
providing characterization of the structural properties of oligomers only in the most general terms (see for exam-
ple Table S1 in ref.10). Alternative methods of structure analysis that would provide experimental insight into each 
of the co-existing species and their dynamic nature need to be explored.
Mass spectrometry (MS) appeared recently as the most promising new alternative, complementing classic 
methods in the study of oligomerization processes11–13. In native MS mode14, mass measurements enable the sep-
aration of signals originating from oligomers of different order (i.e., of different molecular mass). When coupled 
with ion mobility (IM-MS), the technique also allows the separation of signals from different structural variants 
of oligomers of the same order and measurement of their collisional cross section (Ω, Å2). Therefore it allows 
for characterization of the structural properties of each form in separation. Recently, IM-MS has appeared as 
a new tool for analysis of oligomerizing molecules15,16, along with Aβ and its variants17,18. When coupled with 
hydrogen deuterium exchange (HDX), in solution or gas phase, MS provides insight into the structural dynamics 
of different oligomeric forms. Combining these approaches provides a unique analytical tool for species-specific 
structural characterization of forms coexisting in solution19. This methodology may extend knowledge on the oli-
gomeric structures despite the necessity to transfer the molecules from solution to the gas phase. Gas-phase HDX, 
monitored at millisecond times after gentle ionization, has been proven capable of probing solution-like confor-
mational states of peptides, oligomers, and proteins20–22. Since the correspondence of in-solution and gas-phase 
structures cannot be granted, we have also included dynamic light scattering (DLS) analyses of in-solution oli-
gomeric distributions. DLS is more sensitive for larger (>100 kDa) species, but it also provides information on 
smaller species that can be detected by MS.
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We previously analyzed the IM-MS spectra of WT Aβ 1–40 and found that the population of oligomers of 
a given order (e.g. trimers, tetramers, pentamers, etc.) splits into two distinct structural variants, differing in 
their collisional cross section and, therefore, their structure17. Oligomers of the same order exhibit either more 
extended or more compact structures (see for example Fig. 2 in ref.17). We have also analyzed gas-phase HDX for 
these forms and shown increased protection from exchange in oligomers, compared to monomers10. Gas-phase 
HDX explores the involvement of side-chain exchangeable protons and not main chain amide protons, probed in 
classic solution HDX. Therefore, our results demonstrate the oligomer-stabilizing involvement of Aβ side-chain 
protons in H-bonding networks. The majority of side-chains with exchangeable protons are localized within the 
N-terminal 1–16 region of Aβ. The role of the N-terminus in shaping oligomeric equilibria has only started to 
emerge, and the H-bonding network, involving the N-terminal side-chains in oligomers, requires more detailed 
characterization.
Within the N-terminal 1–16 sequence are 12 residues with side-chains that are able to participate in 
H-bonding, including three histidines at positions 6, 13, and 14 (marked in Fig. 1). A notable number of studies 
have documented that these histidine residues influence the neurotoxic properties of the peptide23–26. In particu-
lar, the substitution of His14 by alanine, unlike His6 and His13, has been shown to lead to loss of toxicity27. Other 
results indicate that the peptide must be at least dimeric to exert membrane binding-mediated toxicity28,29.
Cu(II) binding is another putative physiological/toxic function of His moieties. Cu(II)-Aβ complexes have 
been proposed to participate in Aβ toxicity via redox chemistry, including generation of reactive oxygen species, 
and/or enhancement of aggregation and cell binding ability, including Aβ ion channel activity and membrane 
interactions25,27,30–34. AD patients exhibit abnormal accumulation of metal ions (Cu(II) and Zn(II)) in Aβ aggre-
gates, senile plaques, and synaptic areas of the brain35–37. Aβ peptides self-associate faster in the presence of 
Cu(II) ions, with distinct morphological features. The Cu(II) ions may stabilize various structures and initiate and 
enhance the formation of toxic oligomers and aggregates30,38–40. Binding depends on pH because nearly all Cu(II) 
binding residues present in peptides (without Met, which does not participate in the Cu(II) binding in Aβ) are 
reversibly protonated, and the Cu(II) binding occurs via displacement of these protons30,41–43. Metal binding sites 
are localized in the N-terminal part of Aβ34,44–48. Accordingly, the structure of the binding site has been analyzed 
in a number of studies on the truncated versions of the peptide, such as Aβ 1–16. Interestingly, there are also lines 
of evidence for the formation of a Cu2+ complex with two Aβ molecules, which may be considered as dimeric 
species49–51.
As neurotoxicity is inherently connected to the ability of the peptide to oligomerize, mapping the determi-
nants that define this ability is critically important. Therefore, to better understand the molecular mechanisms 
affecting the oligomeric distributions of Aβ 1–40 mediated by the hydrophilic N-terminal residues, we character-
ized the role of each of the Aβ His moieties in oligomerization. For this purpose, we characterized the structural 
properties of different oligomeric forms coexisting in solution in Aβ 1–40 and its three variants, H6A, H13A, and 
H14A, in the absence and presence of Cu(II) ions by combining dynamic light scattering (DLS) of oligomeric 
ensembles in solution with the MS-based analytical tools.
Results
The aim of this work was to characterize the changes in oligomeric patterns of Aβ 1–40 upon substitution of each 
of histidine residue by alanine. For this purpose, we used DLS and MS-based techniques. The properties of three 
point mutants of peptide Aβ 1–40 (H6A, H13A, and H14A) were compared to WT Aβ 1–40. DLS measurements 
allowed us to characterize the oligomeric distributions directly in solution. The MS-based analyses, which allowed 
us to resolve signals originating from oligomers of different orders and their structural variants, included IM and 
HDX in the gas phase, both in the apo form and in the Cu(II)-bound form. From IM-MS measurements, the 
Figure 1. Placement of His residues within WT Aβ 1–40 sequence. Side-chain moieties of histidines are 
highlighted in red. PDB structure 2LFM was used.
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collisional cross section (Ω, Å2) values of different oligomeric forms could be compared, whereas application of 
HDX provided insight into the involvement of side-chain exchangeable protons in intramolecular or intermolec-
ular H-bonding networks.
The results of DLS analysis of four variants of the peptide are presented in Fig. 2 in the form of the autocor-
relation function (ACF) of the scattered light, which allows characterization of the distribution of oligomeric 
sizes. The following four parameters of the ACF curve were taken into account to interpret the results obtained 
in the analysis of solutions of Aβ 1–40 and its three variants: (1) the value of the signal at the shortest observable 
correlation time (i.e., 0.5 μs (ACF0)), the smaller the fraction of monomers, the higher the intersection value of 
the ACF curve with the vertical axis at this correlation time; (2) the initial short-time asymptote of ACF, which 
reflects the presence of small oligomers; (3) the location of the midpoint of the transition (M), higher values in 
the time domain indicate larger aggregates; and 4) the general shape of the ACF, which reflects the homogeneity 
of the sample, as highly heterogeneous solutions have wide ACF transitions, whereas homogeneous distributions 
reveal a sharp transition.
The average values of the two parameters, ACF0 and M, for four variants with no metal added or with 1:1 
Cu:peptide stoichiometry (also 1:2 in case of H6A) are shown in Table 1. In the apo form, the signal value at 
ACF0, at the intersection with the vertical axis, was the highest for H13A (0.67); for WT it was intermediate (0.49) 
and much lower for H14A (0.35) and H6A (0.26). Mutation of His to Ala at position 13 increased the fraction of 
oligomers compared to monomers, whereas at position 14 or 6 it decreased the oligomeric fraction. The largest 
impact was noted for H6A with an ACF0 of 0.26. In the case of H6A, the mixture was characterized by a very 
high fraction of monomers, though the reproducibility was worse with this mutant for an undetermined reason. 
Depending on the position, the His moiety in the WT peptide either decreased (His13) or increased (His14, 
His6) the fraction of monomers. It has to be stressed that the ACF0 value does not allow to measure the absolute 
fraction of monomeric species, for instance ACF0 of 0.5 does not imply 50% of monomers in solution. The exper-
imental ACF function is the weighted average of ACF functions for all species in the solution, with individual 
weights scaled both by efficiency of scattering (proportional to diameter of an oligomer as r^6) and by concen-
tration. So, the apparent contribution of low-order oligomers to ACF is substantially lower than that for the same 
number of molecules associated in high-order aggregates.
Figure 2. Dynamic light scattering (DLS) experiment of WT Aβ 1–40, and its three variants. Representative 
autocorrelation functions (ACFs) directly adapted from dynamic light scattering data obtained for WT Aβ 
1–40 (black), H6A (orange), H13A (blue), and H14A (green) (a) and data collected in the presence of metal ion 
Cu(II). (b) Cu(II) was added in 1:1 stoichiometry, or 1:2 stoichiometry in the case of H6A (dotted orange). The 
ACF decays in the range of 1 down to 0, and the gap remaining to 1 observed at the shortest correlation time is 
indicative of the existence of monomeric or low-order oligomers, which remain undetectable. Results of three 
independent experiments are shown.
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The fraction of lower-order oligomers is also reflected in the initial slope of the ACF curve. A larger slope, as 
observed with H6A and H14A, indicates larger populations of low-order oligomers compared to WT and H13A, 
where larger oligomers were preferentially populated (Fig. 2a). For H13A, this was accompanied by the narrowest 
distribution of oligomeric forms reflected in the sharpest transition between forms characterized by small corre-
lation times (small oligomers) and large correlation times, representing the larger species. For WT and the two 
remaining variants, this distribution was broader. The replacement of His13 with Ala resulted in a more homo-
geneous distribution of oligomers than that observed for WT, with a decreased fraction of small oligomers. The 
H13A mutation also led to oligomers of an increased average size, as reflected in the M values in Table 1, whereas 
the other two mutants yielded smaller average oligomers. In conclusion, oligomeric distributions in solution 
proved to be highly sensitive to the presence or absence of single His moieties and their positions, with adverse 
effects observed for H13A and H6A/H14A. Our data reveal very strong and position-dependent participation 
of these hydrophilic, N-terminal residues in shaping the oligomeric equilibria. Though His6 critically stabilizes 
oligomers, the effect can be intermediate, as with His14, or even opposite, as with His13, the presence of which 
destabilizes oligomers in WT peptide.
Interestingly, narrower and more homogeneous distributions of ACF were induced in all four variants when 
Cu(II) was added in 1:1 stoichiometry (1:2 in the case of H6A) (Fig. 2b). In the presence of Cu(II), the ACF curves 
of WT, H13A, and H14A, and thus their oligomeric distributions, were very similar to each other (Fig. 2b) and 
similar to H13A in apo form. For H6A at 1:1 stoichiometry, the ACF curve differed from WT, but at 1:2 pep-
tide:metal stoichiometry they also become similar to WT (Fig. 2b). Therefore, upon addition of metal, the frac-
tion of oligomers increased in WT, H14A, and H6A, but for H13A it remained unchanged. For WT and H14A, 
the oligomerization became as efficient at 1:1 stoichiometry of Cu(II) as observed for H13A in both the apo and 
Cu(II)-bound form. Therefore, the oligomer-destabilizing effect of the His13 moiety, which was observed in the 
apo form, is removed by Cu(II) binding. On the other hand, the stabilizing effect of His14 observed in the apo 
form is absent in the presence of metal ion. Thus, specific oligomer-destabilizing (His13) and stabilizing (His14) 
interactions become substituted upon Cu(II) addition by the interactions with the metal ion. When coordinated 
to the Cu(II) ion, His13,14 moieties lose their ability to participate in other interactions and their impact on oli-
gomer distribution decreases, so that oligomeric distributions in the presence of Cu(II) no longer depend on the 
presence of the His13 and His14 moieties. Substitution of the His6 moiety requires higher metal concentrations 
to become compensated. This indicates a key role of His6 as a metal-induced oligomer-ordering moiety, in agree-
ment with its known role as the main Cu(II) binding residue52.
In the presence of Cu(II), the median M position was strongly shifted to longer times (WT, 845 μs; H13A, 
922 μs; H14A, 768 μs; H6A, 853 μs at 1:2 stoichiometry), indicating larger average masses of Cu-bound oli-
gomers, similar for each variant and similar to H13A apo. The transition becomes sharper in the case of all four 
variants, and the oligomeric distributions become more homogeneous in the presence of metal. Independent of 
the composition of the Cu(II)-binding moieties, metal binding enforces a more uniform, homogeneous align-
ment of monomers into oligomers.
Though DLS provides a more sensitive signals for relatively large (>100 kDa) oligomers it also allowed to 
compare the populations of low-order oligomers in the mutants. Such low-order oligomeric native-like forms 
can also be probed by MS-based methods, provided the measurements are carried out within milliseconds after 
electrospray ionization (ESI)16,17. Molecules at this time frame may transiently retain native-like structures in 
the gas phase. Here, the oligomers were subjected to gas-phase HDX at the cone exit in a submillisecond time 
frame after ESI, as described previously10,53. After the exposure of molecules to ND3 in the cone exit, the isotopic 
envelopes resulting from exchange can be analyzed. To compare the exchange between oligomers of different 
orders, it is necessary to limit the comparison to oligomeric states bearing the same charge per monomer due 
to high sensitivity of the gas phase structure to the charge state of the molecule. Therefore, exchange in MON2+, 
DIM4+ and TRI6+ forms, all bearing charge 2+ per monomer, was compared in the apo form. In the presence of 
Cu(II), the signal in isotopic envelopes after exchange became too weak to be analyzed. The isotopic envelopes 
of apopeptides after exchange obtained in three replicate experiments are shown in Fig. 3 and Supplementary 
Fig. S1. As noted previously10 for WT, in the majority of cases the isotopic envelopes after exchange were strongly 
split, indicating the coexistence of several structural variants for each oligomeric form at the cone exit, where the 
exchange takes place.
In the first step of the analysis, the average masses after exchange were calculated. Inspection of average uptake 
levels in these forms (Fig. 4a) showed that, upon mutation, the uptake generally increases significantly compared 
to WT. H13A leads to the highest uptake in the monomer (26.7 Da). For H6A it was intermediate, whereas for 
WT
WT 
1:1 Cu H6A
H6A 
1:1 Cu
H6A 1:2 
Cu H13A
H13A 1:1 
Cu H14A
H14A 1:1 
Cu
Signal value 
ACF at 0.5 μs
AV 0.49 0.68 0.26 0.55 0.69 0.67 0.70 0.35 0.72
SD 0.03 0.01 0.13 0.10 0.01 0.01 0.03 0.12 0.07
Midpoint 
ACF [μs]
AV 303 845 104 546 853 457 922 133 768
SD 93 36 143 232 59 159 285 83 26
Table 1. The signal value at the shortest observable correlation time (ACF 0.5 μs) - upper row, and location of 
the midpoint of the transition (Midpoint ACF) – lower row, for four Aβ variants in the absence of metals and 
for 1:1 Cu:peptide stoichiometry (1:2 also in case of H6A). The averages of three independent experiments are 
shown. AV, average; SD, standard deviation. The results of the statistical analysis are presented in Supplementary 
Information Fig. S2.
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H14A it was much lower, nearly as low as for WT (14.4 Da in H14A vs. 11.7 Da in WT). Substitution of His13 led 
to very strong destabilization of the H-bonding network in the monomer. Presence of His13 in WT and H14A is 
sufficient to induce substantial protection. The Aβ 1–40 molecule contains 27 non-amide heteroatom-bound pro-
tons (see Fig. 1B, C in ref.10) that may be exchanged during gas-phase HDX-MS, along with the charging protons. 
Figure 3. Analysis of the isotopic envelopes after gas-phase HDX-MS for selected signals of species bearing 
the same charge per monomer, namely MON2+, DIM4+, and TRI6+ of WT Aβ 1–40 (a) (2164–2185 m/z range), 
H6A (b), H13A (c), and H14A (d) (2130–2155 m/z range). Left panels, Isotopic envelopes corresponding to 
MON2+ (upper panels), DIM4+ (middle panels), and TRI6+ compact and extended forms (lower panels) for 
a make-up gas flow of 40 mL/min in the presence of ND3/D2O reagent. Right panels, Decomposition of the 
experimental isotopic envelope into a family of isotopic envelopes of full width at half maximum (FWHM) 
expected for a single conformational state. The spectra were recalculated from the m/z domain (left panels) 
to the domain of the molecular mass of a monomeric unit in an oligomer (right panels). Masses indicated in 
right panels are weighted average masses of all forms detected. Decomposition methodology described in the 
“Methods” section. Results of replicates of this experiments are shown in Supplementary Fig. S1.
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MON2+ contained two such charge-carrying exchangeable protons, giving a total of 29 exchangeable protons. 
In H13A, the MON2+ form underwent a nearly complete exchange. His13 and His6 seem to be the key moieties 
that stabilize the monomeric structure, whereas His14 is not involved much. Even in the case of monomers, 
the analyzed structures seem to be well defined, as the impact of His moiety removal on the overall exchange is 
starkly position-dependent. In other words, a single His moiety can reconfigure the structures to a high degree in 
a position-dependent way.
The differences in the average extent of exchange between dimers and monomers and between trimers and 
monomers are shown in Fig. 4b. Similar to the situation in WT, the deuterium uptake was markedly lower in H6A 
and H13A oligomers than in monomers. The difference was even more pronounced in these two mutants, espe-
cially H13A, than in WT. In contrast, the effect was absent with H14A, as oligomeric forms took up deuterium 
with the same efficiency as monomers.
The exchange for dimers remained at a similar level regardless of the variant (15.2–15.6 Da per monomer). 
In addition, the trimeric compact form in each variant underwent exchange to a similar extent (14.0 to 16.0 Da 
per monomer). In WT the exchange was on the level of 10 Da in oligomers. The removal of a His moiety depro-
tected oligomers (i.e., destabilized H-bonding networks) to a similar extent in each variant; thus, this effect is not 
position-dependent in the case of oligomers. This is in contrast to monomers, which are very strongly deprotected 
in H13A (mass increased by 15.0 Da compared to WT), much less in H6A (9.6 Da), and only slightly in H14A 
(2.7 Da).
A more detailed analysis of deuterium uptake patterns can be carried out by inspecting the isotopic envelopes 
(Fig. 3 and Supplementary Fig. S1). For the monomeric form of WT (see upper panel in Fig. 3a), the fast exchang-
ing species are minor, whereas for H13A they are dominating, less so for H6A (Fig. 3b,c), and for H14A (Fig. 3d) 
the exchange reveals a wide distribution of states from slow to fast exchanging. A much greater fraction of faster 
exchanging species is present in dimeric forms of all mutants, and isotopic envelopes become much wider, with 
Figure 4. (a) Deuterium content per monomer (HDX/M) of individual charge states of monomer 2+ (black), 
dimer 4+ (green), trimer compact 6+ form (blue), and trimer 6+ extended form (dashed blue) of WT Aβ 
1–40 and mutants induced by gas-phase HDX-MS at a make-up gas flow rate of 40 mL/min, averaged over all 
signals of the appropriate isotopic envelope. Error bars indicate the standard deviation calculated from replicate 
measurements (3 replicates). (b) Difference in deuterium uptake per monomer, as shown in (a), between 
dimers and monomers (green), trimers compact form and monomers (blue), and trimers extended form and 
monomers (dashed blue). The analysis is based on the signals at the m/z region 2164–2169 (for WT) and 2130–
2155 (for mutants) which contain well-resolved isotopic envelopes from MON2+, DIM4+, and TRI6+ oligomeric 
forms bearing the same charge per monomer. The p-values were evaluated by t-test (**p-value < 0,05 or 
*p-value < 0,1).
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multiple forms of different levels of exchange populated. Trimeric forms of H14A also reveal much wider iso-
topic envelopes and the faster exchanging species than WT. For H13A and H6A trimers, the slow exchanging 
species seem to dominate, with even less exchange for the WT trimer compact form, accompanied by a pleth-
ora of less populated faster exchanging species. In conclusion, the effect of His substitution on exchange in apo 
forms is strongly position- and species-dependent. H-bonding networks involving His moieties in oligomers, 
but also monomers, strongly influenced the stabilities of different forms. Compared to WT, the removal of His14 
decreased protection in monomers to a much smaller extent than the removal of His13. In agreement with DLS, 
His13 was the strongest stabilizing moiety for monomer structures.
His moieties may stabilize monomers and oligomers to a different extent, so these interactions may change 
their mutual population. For example, H13A seems to destabilize intra-molecular H-bonding networks in mono-
mers to such an extent that it leads to a relative increase in the fraction of oligomers, as observed in DLS (Fig. 2a). 
In the other two variants (H6A and H14A), DLS revealed a decreased oligomeric fraction. For these two variants, 
the decreased protection of the monomeric species was much smaller, whereas decreased protection of oligomers 
remained the same as for H13A. For H6A and H14A, intramolecular interactions seem to be affected by the 
substitutions to a much smaller extent than H13A, whereas oligomer-supporting intermolecular interactions are 
affected to the same extent. The analysis of DLS and HDX indicates that His13 more strongly stabilizes monomers 
than oligomers, shifting the equilibrium in WT towards the monomeric form, as observed in DLS. For His6, the 
effect is the opposite, whereas His14 stabilizes oligomers but has only a weak effect on monomers, leading to an 
increase in the fraction of oligomers observed in DLS. His6 and His13 residues provide strong structure stabiliza-
tion for monomers and oligomers. His14 has only a weak effect on monomers but stabilizes oligomers.
All three single site substitutions of His residues to Ala led to significant changes in the IM drift time distri-
butions compared to WT, even in the apo form. The distributions of species in the drift time domain for selected 
mass ranges, corresponding to different oligomeric forms, are shown in Fig. 5. The inspection of drift time profiles 
shows that the positions of the signals on the drift time axis (i.e., the collisional cross section Ω values of corre-
sponding forms and, thus, their overall shapes) did not change significantly, with the exception of TRI7+ extended 
form (Fig. 5b). However, the relative population of compact and extended oligomeric forms was significantly 
changed in the mutants. This can be observed for TRI6+ and 7+, TET6+ and7+, and PEN8+ and9+ (Fig. 5a–f). In 
general, regardless of the position of His in the sequence, its absence depletes the compact form relatively more 
than the extended form. His residues at any position participate in the network of interactions, supporting the 
compact oligomeric form more than the extended form.
Cu(II) binding to mutants led to relative stabilization of the compact form, reverting the result of the mutation 
to some extent. Previously, we found that the binding of a metal ion in WT also stabilizes the compact forms, 
more strongly for Cu(II) than for Zn(II)54. However, the mutants exhibited increased populations of the extended 
apo form so in the mutants the Cu(II)-induced stabilization did not lead to such a strong domination of the 
compact form. In the cases of DIM5+, TRI7+, and TET7+ (Fig. 6a–c), the fraction of extended form versus com-
pact form was much higher in the mutants than in WT. The stabilization of the compact form by Cu(II) binding, 
combined with the observation that this binding led to larger but more homogeneous oligomers in DLS, led to 
the conclusion that compact oligomeric forms are larger on average than the extended forms and presented a 
narrower distribution of states, especially when stabilized by metal.
Discussion
Our results indicate that the His6, 13, and 14 moieties influence Aβ 1–40 oligomeric equilibria in a 
position-specific way. Their impact is much stronger in the absence of Cu(II) than in its presence. All three his-
tidines are localized in the hydrophilic N-terminal portion of the Aβ sequence. The amyloidogenic properties 
thought to underlie neurotoxicity55 are encoded by hydrophobic residues characterized by β-structure propen-
sities and localized mainly within the C-terminus56. However, N-terminally truncated peptide variant 17–40/42 
(the so-called p3 peptide) is a natural product of the alternative “non-amyloidogenic” pathway of amyloid pre-
cursor protein cleavage57. Neurotoxic forms of Aβ peptide are expected to solely be the result of the “amyloido-
genic” pathway. For this reason, p3 is thought to be benign56,58, though its role was not studied in depth59. If p3 is 
non-neurotoxic, then the presence of the N-terminus critically influences different aspects of oligomer toxicity, 
which may include pathologic oligomerization. The importance of the N-terminal part of Aβ was also verified 
by the analysis of mutations in the Aβ gene, which may cause familial AD (e.g., A2V, H6R-English, D7N-Tottori, 
D7H-Taiwanese) or be preventive (A2T)60. In addition, the position of residues involved in metal ion binding 
is localized in the N-terminal sequence and seems to be a critical agent shaping the Aβ fibrillogenic proper-
ties61,62. The present study complements our previous work10 in which we showed sequence-specific involvement 
of the N-terminal residues in the H-bonding network of oligomer-stabilizing interactions. We have also pro-
posed a molecular mechanism by which this network of interactions may be crucial for the effective evolution of 
oligomers into higher-order structures. In the present study, we defined three residues that actively participate 
in this network. We have also shown that this impact is strongly position-dependent to the extent that, in the 
absence of Cu(II), His14 increases the population of oligomers in Aβ, whereas His13 decreases it.
The involvement of the N-terminus in the oligomer structure was previously noted in a classic HDX study 
that found a significant protection of N-terminal amides (res. 1–11) (see Fig. 8 in ref.63) in oligomeric species. The 
N-terminal region has been found to not be ordered in the majority of fibril structures64, but ordered N-terminal 
residues have also been reported65. The presence of “order” in this region was accompanied by substantial 
exchange at a set of N-terminal amides, contrasting with strong protection of the C-terminus, representing the 
core of the amyloid. Therefore, the N-terminus was ordered but more dynamic than the core region. His13 and 
His14 side-chain protons may also be protected from exchange in fibrils66.
Differences in the abundance of small oligomers between the three His to Ala variants in the 1–42 version 
were also observed previously by PICUP27. Combined with di-tyrosine formation analysis, membrane binding 
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tests and the non-toxicity of H14A to primary cortical neurons allowed authors to conclude that His14 is critical 
for neurotoxicity due to a combination of reduced membrane-binding ability and less efficient di-tyrosine for-
mation. On the other hand, Hung et al. showed that neurotoxicity correlates with the lipid-binding efficiency of 
dimers and trimers, but not monomers. Therefore, oligomerization seems to precede toxicity; oligomers have to 
be formed first, before the toxic effect can be revealed28. Interactions that destabilize or stabilize oligomers also 
influence neurotoxicity, though not necessarily directly.
The intriguing finding of the present study was that Cu(II) binding largely diminished the differences in oli-
gomer distribution between WT, H13A, and H14A and led to a more uniform set of larger species, independent 
of the presence or absence of a His residue at either of these two positions. Histidine residues serve as metal 
coordination sites. In monomers, the binding modes are well characterized; Cu(II) is known to be coordinated at 
a neutral pH to three nitrogen atoms (3 N complex). The major component includes the N-terminal amine, the 
His6 imidazole, and one of the two remaining imidazoles, His13 or His14. Alternative binding modes may engage 
the N-terminal amine, the neighboring peptide amide, and one of the His imidazoles. In the case of monomers, 
which are assumed to be structurally heterogeneous and dynamic, the imidazole donors are interchangeable. 
Therefore, a missing moiety at position 13 or 14 may be readily substituted by the remaining coordination imi-
dazole. Molecular models of Cu(II) binding to oligomeric structures (Fig. 6 in ref.54) suggest that the binding 
modes in which two His moieties juxtaposed in the neighboring monomers align in a parallel fashion provide 
imidazoles for alternative inter-monomeric coordination of a single Cu(II) ion. In H13A, complexes engaging 
Figure 5. IM-MS drift time profiles of signal groups at selected regions (a–f) corresponding to WT Aβ 1–40 
(black), H6A (orange), H13A (blue), and H14A (green) oligomers. For each selected m/z region, a profile of 
molecular species present at different drift times in the IM T-wave is shown, with each species assigned to a 
particular oligomeric charge state. These profiles represent signals that are split in the domain of the drift time, 
indicating the presence of multiple species, as marked. Species identification was carried out previously17.
9Scientific RepoRts |          (2019) 9:9449  | https://doi.org/10.1038/s41598-019-45988-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
two neighboring His14 moieties are possible, whereas in H14A the coordination via two His13A is still possible. 
In agreement with the structural models in which the chains in oligomers run parallel, these coordination modes 
of Cu(II) ions would stabilize oligomeric forms with a strict in-register parallel ordering of chains, regardless of 
the involvement of the His13 or His14 moieties, or both. As a result, structures become similar after Cu(II) ion 
binding. In addition, the Cu(II) binding by His13 in WT and H14A, engaging the His13 residue, releases the 
oligomer-destabilizing interactions of His13, and the differences observed between H13A and WT and H14A in 
Figure 6. IM-MS drift time profiles of three selected regions corresponding to DIM5+ (a), TRI7+ (b) and TET7+ 
(c) species, extracted from spectra of WT Aβ 1–40, H6A, H13A and H14A collected in the presence of metal 
ions Cu(II), Cu(II) bound in complexes at different ratios (CunLm), where L indicates metal-liganding peptide 
molecule. Drift time profiles present complex of ligand-particular oligomeric charge state (Lm) with different 
amounts number n of metal ions (Cun), CuLm (pink), Cu2Lm (purple) and compared to the control spectra 
collected in the absence of metals (black).
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terms of the oligomer population of their apo forms are no longer observed upon Cu(II) binding. This provides 
an additional reason for the observed similarity in oligomer distributions and their increased homogeneity in 
WT, H13A, and H14A in the presence of divalent copper. Our results indicate a unique role of Cu(II) binding as 
an oligomer-ordering mechanism.
In conclusion, His residues have a strong, position-dependent impact on oligomer populations. Not only the 
hydrophobic amyloidogenic side-chains are important for the structural evolution of oligomeric forms, but also 
other interactions, including the N-terminal hydrophilic residues.
Methods
General. MS and DLS experiments were carried out essentially as described previously10. Description of these 
experiments is reproduced here.
Aβ variant expression. Aβ 1–40 peptide and its variants were obtained by expression in Escherichia coli 
and purified using HPLC as described previously67. Peptide variants were obtained by site-directed mutagenesis 
(Stratagene Kit). Aβ peptide mutants have changes at positions H6A, H13A, and H14A. The identity and purity 
of each molecule was verified using a Q-ToF Premier ESI-MS instrument (Waters). Typically, the concentration 
of the peptide in the stock solution was 100 μM and the pH adjusted to 7.4 with ammonia. The freshly purified 
Abeta1–40 WT and its variants after HPLC were used in all types of analysis. All experiments were carried out 
immediately after the LC purifications step and mass and concentration measurements. ThT binding experiments 
carried out using stock solutions (Supplementary Fig. S4) showed that the experiments were completed within 
the lag phase of fibril formation so in the absence of fibrils. NaOH, HCl, Tris, and 26% ammonia-D3 in D2O 
99.5% (ND3/D2O) were purchased from Merck (Darmstadt, Germany) and ammonium acetate from Fluka (the 
Netherlands).
Cu(II) experiments. Copper(II) acetate was purchased from Sigma-Aldrich Chemical Co. Metal solutions 
were prepared from weighed amounts using analysis grade water (Baker) to obtain concentrations of 9.4 mM 
(Cu). The concentration of Cu(CH3COO)2 was verified using the Lambert–Beer law (A = εlc) with a molar 
extinction coefficient value for Cu2+aq of 12.0 M−1 cm−1 at λ = 810 nm68.
Ion mobility mass spectrometry. Experiments were performed using a hybrid Q-TOF mass spectrometer 
with ion mobility capabilities (Synapt G2 HDMS; Waters Corp., Wilmslow, UK). Samples of Aβ 1–40 WT, H6A, 
H13A, and H14A at 100 μM in 10 mM CH3COONH4 (pH 7.4, when necessary the pH was adjusted with ammo-
nia) with or without addition of Cu(CH3COO)2 were infused directly at 7 μL/min into the ion source of a mass 
spectrometer using a glass Hamilton syringe through a stainless steel capillary. The mass signals were measured 
in the 400–4000 m/z range at the rate of 1 scan per second. The analyzed spectra were the average of 200 scans. 
The instrument was tuned to obtain the best possible signal and HDX efficiency using the electrospray positive 
ion mode with a capillary voltage of 2.8 kV and a sample cone voltage of 37 V. The source and desolvation temper-
atures were maintained at 85 °C and 180 °C, respectively. The mobility T-wave cell was operated at a pressure of 
2.5 mbar of nitrogen, with a wave velocity of 300 m/s and amplitude (T-wave height) of 40 V. Data acquisition and 
processing were carried out with the MassLynx V4.1 (Waters) and DriftScope V2.1 (Waters) software supplied 
with the instrument. Each analysis of drift time profiles for Aβ WT, H6A, H13A, and H14A was carried out under 
the same experimental conditions. All data were repeated for batch-to-batch replicates (n = 3 or more) to confirm 
the reproducibility of the results.
Gas-phase HDX-MS. Gas-phase HDX-MS was performed in the ion source region of a commercially avail-
able Synapt G2 HDMS instrument immediately downstream of the primary cone exit (sample cone) as described 
elsewhere53. Briefly, 2.0 ml of aqueous ND3/D2O reagent was added to the standard ETD reagent vial with the 
ETD reagent removed. To control reagent flow, the mass spectrometer software was set in ETD-mode with 
a HDX reagent gas flow rate of 0–50 mL/min (N2 gas); 50 mL/min is the maximum setting on the Synapt G2 
HDMS instrument. N2 gas was passed through the headspace of the reagent pot and through a needle (corona 
discharge needle) downstream of the primary cone exit. The trap T-Wave wave height was set to +6.0 V to prevent 
unwanted electron transfer reactions in the case of residual ETD reagent in the tubing. Control experiments were 
also performed under identical conditions with the only difference being the presence of non-deuterated NH3/
H2O instead of ND3. This procedure allowed us to test whether the presence of a basic gas would affect the exper-
iment, and no changes in ionization, adduct formation, or conformation were observed.
Data analysis. Processing of all mass spectra was carried out using MassLynx V4.1 software with a 
Savitzky-Golay smoothing function (3, 5) and subsequent centering of the peaks. The deuterium content of pep-
tides was determined using Excel 2013 (Microsoft Corp., Redmond, WA, USA) by calculating the difference in 
the intensity-weighted centroid average masses of deuterated ions with respect to those from a non-deuterated 
control sample recorded in the absence of ND3 gas. All data were derived from at least three or more replicate 
measurements.
An in-house procedure was developed for deconvolution of the complex, split isotopic envelopes corre-
sponding to the differently exchanging species. First, the procedure allowed us to calculate the mass distributions 
expected at each stage of exchange for a single uniform conformation of a peptide of a given mass and number 
of exchangeable protons. The calculation was carried out using a simplifying assumption of equal probability of 
exchange for each exchangeable proton. If the probability was not equal (which is highly likely), the distributions 
necessarily became narrower. Thus, the result of this assumption is that we could model the widest possible 
distribution expected for a single state. As a result, the number of detected states may only be higher, but cannot 
be lower. Using this approach, we thus identified the minimum number of states present during exchange that 
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would account for the experimental distributions. As a result of the first step a set of 200 theoretical uniformly 
deuterated single-state distributions ranging from 0% to 100% deuterium uptake was simulated for each sample. 
For the deconvolution procedure, both centrioided experimental distributions and theoretical distributions were 
represented as 500-element vectors, calculated by convolution with a Gaussian function and sampling at points 
uniformly distributed along the specified mass range of theoretical isotopic envelopes. The resulting linear equa-
tions were solved using boosted Gold algorithm as described in ref.69. with 10000 iterations, 100 boosting steps 
and p = 1.2. This allowed us to obtain a linear combination of single-state distributions that fits the measured 
distribution while meeting physical constraints (small number of non-zero elements, no negative elements). In 
case of two neighboring non-zero elements in the solution vector, only a single component distribution was 
reported in the results, with deuterium uptake linearly interpolated between theoretical uptakes corresponding 
to these elements.
Dynamic light scattering. All DLS experiments were carried out at 25 °C with a DynaPro NanoStar appa-
ratus (Wyatt Technology, Santa Barbara, CA, USA) equipped with a 661 nm laser and the 90 detection angle. The 
ACF for the light scattered by Aβ WT, H6A, H13A, and H14A (at 100 μM in 10 mM CH3COONH4, pH 7.4) with 
or without addition of Cu(CH3COO)2, solution placed in an Eppendorf UVette disposable cuvette (50–2000 μL) 
was measured and further analyzed in the range of 0.5 μs to 0.2 s using Dynamics software (Wyatt Technology, 
ver. 7.0.2.7). All samples were filtered with 0.45-μm pore syringe filter and additionally centrifuged (9000 g) for 
3 minutes directly before the measurement. For each sample, a series of at least three successive repetitions, 50 
acquisitions of 10 s each, were collected, and these 10 s accumulations with abnormally high SOS function and/
or highly fluctuating SLS signals were removed from further analysis. As no apparent time trend in SLS data were 
observed, the DLS data collected upon the first repetition (i.e., during the initial 10 min after sample dilution) 
were averaged and further analyzed.
Statistical analysis. All statistical analyses were performed using R package (version 3.4.1.; The R 
Foundation for Statistical Computing, Vienna, Austria). Fisher F-test was applied to asses identity of ACF func-
tion recorded for individual peptides. The ratio of residual variance was analysed according to F-test. Since for 
each peptide three independent replicates were analysed, every pair of peptides leads to six ACF curves from six 
independent experiments. H0 hypothesis claims that all six experiments originate from the same oligomeric dis-
tribution, which is represented by the average of six analysed ACF curves. The alternative hypothesis (H1) claims 
that six curves originate from two different distributions represented by two average ACF functions calculated 
separately for each variant. Fisher F-test estimates the probability of that these residual variances are equal, i.e. 
H0 hypothesis cannot be rejected. Residual variances were analysed with 5 N and 4 N degrees of freedom, respec-
tively, where N = 266 is a number of data-points recorded in the range of 0.5 μs to 0.1 s. Results shown in Fig. 4b 
were subjected to t-test analysis of the differences between exchange in monomers and oligomers, testing the H0 
hypothesis that the difference is zero.
Thioflavin T fluorescence assay. Commercially available Thioflavin T (ThT) was purchased from Sigma 
Aldrich and a stock solution of concentration 2,5 mM in Mili-Q water was prepared and stored the solution at 
−18 °C. Freshly received stock samples of Aβ 1–40 WT, H6A, H13A, and H14A in 10 mM CH3COONH4 (pH 7.4, 
when necessary the pH was adjusted with ammonia) were prepared to perform the fluorescence study, appropri-
ate volume of peptide sample was taken out from the stock solution and was mixed with 10 μL of ThT solution 
(2,5 mM); to accomplish final peptide and ThT concentration of 100 μM, final volume was made up to 250 μL in 
10 mM CH3COONH4. For ThT fluorescence assay, emission was measured from 450 nm to 650 nm and excitation 
at 440 nm, using a slit of 1 nm on a FP-6500 spectrofluorometer instrument (Jasco, Tokyo, Japan). The content of 
the cuvettes was pipetted up and down before every measurement. The fluorescence was measured at various time 
points, up to 72 h after the final SpeedVac purification step. From the machine text file was taken and graphs were 
plotted using OriginPro software (version 8, OriginLab Corporation, Massachusetts, USA).
Data Availability
All data generated or analyzed during this study are included in this published article.
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